Like CD27‐, CD70‐deficient patients, RASGRP1‐deficient patients appear to be particularly prone to develop EBV‐driven B‐cell lymphoma as the four patients described today had Hodgkin lymphoma. This evidence concerns the gene CD27 and B-cell non-Hodgkin lymphoma.